121 related articles for article (PubMed ID: 15795916)
1. Acute leukemia associated with valproic acid treatment: a novel mechanism for leukemogenesis?
Coyle TE; Bair AK; Stein C; Vajpayee N; Mehdi S; Wright J
Am J Hematol; 2005 Apr; 78(4):256-60. PubMed ID: 15795916
[TBL] [Abstract][Full Text] [Related]
2. Translocation-positive acute myeloid leukemia associated with valproic acid therapy.
Williams DC; Massey GV; Russell EC; Riley RS; Ben-Ezra J
Pediatr Blood Cancer; 2008 Mar; 50(3):641-3. PubMed ID: 17262798
[TBL] [Abstract][Full Text] [Related]
3. Results of a phase 2 study of valproic acid alone or in combination with all-trans retinoic acid in 75 patients with myelodysplastic syndrome and relapsed or refractory acute myeloid leukemia.
Kuendgen A; Knipp S; Fox F; Strupp C; Hildebrandt B; Steidl C; Germing U; Haas R; Gattermann N
Ann Hematol; 2005 Dec; 84 Suppl 1():61-6. PubMed ID: 16270213
[TBL] [Abstract][Full Text] [Related]
4. Acute seizures due to a probable interaction between valproic acid and meropenem.
Coves-Orts FJ; Borrás-Blasco J; Navarro-Ruiz A; Murcia-López A; Palacios-Ortega F
Ann Pharmacother; 2005 Mar; 39(3):533-7. PubMed ID: 15701769
[TBL] [Abstract][Full Text] [Related]
5. The histone deacetylase (HDAC) inhibitor valproic acid as monotherapy or in combination with all-trans retinoic acid in patients with acute myeloid leukemia.
Kuendgen A; Schmid M; Schlenk R; Knipp S; Hildebrandt B; Steidl C; Germing U; Haas R; Dohner H; Gattermann N
Cancer; 2006 Jan; 106(1):112-9. PubMed ID: 16323176
[TBL] [Abstract][Full Text] [Related]
6. Clinical trial of valproic acid and all-trans retinoic acid in patients with poor-risk acute myeloid leukemia.
Bug G; Ritter M; Wassmann B; Schoch C; Heinzel T; Schwarz K; Romanski A; Kramer OH; Kampfmann M; Hoelzer D; Neubauer A; Ruthardt M; Ottmann OG
Cancer; 2005 Dec; 104(12):2717-25. PubMed ID: 16294345
[TBL] [Abstract][Full Text] [Related]
7. Monosomy 7 with severe myelodysplasia developing during imatinib treatment of Philadelphia-positive chronic myeloid leukemia: two cases with a different outcome.
Navarro JT; Feliu E; Grau J; Espinet B; Colomer D; Ribera JM; Oriol A; Granada I; Juncà J; Millá F
Am J Hematol; 2007 Sep; 82(9):849-51. PubMed ID: 17563075
[TBL] [Abstract][Full Text] [Related]
8. Impact of trisomy 12, del(13q), del(17p), and del(11q) on the immunophenotype, DNA ploidy status, and proliferative rate of leukemic B-cells in chronic lymphocytic leukemia.
Quijano S; López A; Rasillo A; Sayagués JM; Barrena S; Sánchez ML; Teodosio C; Giraldo P; Giralt M; Pérez MC; Romero M; Perdiguer L; Orfao A
Cytometry B Clin Cytom; 2008 May; 74(3):139-49. PubMed ID: 18061951
[TBL] [Abstract][Full Text] [Related]
9. Histone deacetylase inhibitor treatment downregulates VLA-4 adhesion in hematopoietic stem cells and acute myeloid leukemia blast cells.
Mahlknecht U; Schönbein C
Haematologica; 2008 Mar; 93(3):443-6. PubMed ID: 18268283
[TBL] [Abstract][Full Text] [Related]
10. Pancreatitis, complicated by a pancreatic pseudocyst associated with the use of valproic acid.
Houben ML; Wilting I; Stroink H; van Dijken PJ
Eur J Paediatr Neurol; 2005; 9(2):77-80. PubMed ID: 15843073
[TBL] [Abstract][Full Text] [Related]
11. On the toxicity of valproic-acid.
Moreiras Plaza M; Rodríguez Goyanes G; Cuiña L; Alonso R
Clin Nephrol; 1999 Mar; 51(3):187-9. PubMed ID: 10099893
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up of a patient with idiopathic myelofibrosis associated with chromosome 11 and 13 abnormalities.
Toubai T; Tanaka J; Higa T; Ota S; Ibata M; Shono Y; Mashiko S; Miura Y; Umehara S; Kahata K; Toyoshima N; Morioka M; Asaka M; Kasai M; Imamura M
Am J Hematol; 2005 Jan; 78(1):67-70. PubMed ID: 15609290
[TBL] [Abstract][Full Text] [Related]
13. Increase in platelet count in older, poor-risk patients with acute myeloid leukemia or myelodysplastic syndrome treated with valproic acid and all-trans retinoic acid.
Pilatrino C; Cilloni D; Messa E; Morotti A; Giugliano E; Pautasso M; Familiari U; Cappia S; Pelicci PG; Lo Coco F; Saglio G; Guerrasio A
Cancer; 2005 Jul; 104(1):101-9. PubMed ID: 15895376
[TBL] [Abstract][Full Text] [Related]
14. Fluorescence in situ hybridization analysis of 110 hematopoietic disorders with chromosome 5 abnormalities: do de novo and therapy-related myelodysplastic syndrome-acute myeloid leukemia actually differ?
Lessard M; Hélias C; Struski S; Perrusson N; Uettwiller F; Mozziconacci MJ; Lafage-Pochitaloff M; Dastugue N; Terré C; Brizard F; Cornillet-Lefebvre P; Mugneret F; Barin C; Herry A; Luquet I; Desangles F; Michaux L; Verellen-Dumoulin C; Perrot C; Van den Akker J; Lespinasse J; Eclache V; Berger R;
Cancer Genet Cytogenet; 2007 Jul; 176(1):1-21. PubMed ID: 17574959
[TBL] [Abstract][Full Text] [Related]
15. Myelodysplastic syndrome associated with chronic valproic acid therapy: a case report and review of the literature.
Allan RW
Hematology; 2007 Dec; 12(6):493-6. PubMed ID: 17852444
[TBL] [Abstract][Full Text] [Related]
16. Sequential valproic acid/all-trans retinoic acid treatment reprograms differentiation in refractory and high-risk acute myeloid leukemia.
Cimino G; Lo-Coco F; Fenu S; Travaglini L; Finolezzi E; Mancini M; Nanni M; Careddu A; Fazi F; Padula F; Fiorini R; Spiriti MA; Petti MC; Venditti A; Amadori S; Mandelli F; Pelicci PG; Nervi C
Cancer Res; 2006 Sep; 66(17):8903-11. PubMed ID: 16951208
[TBL] [Abstract][Full Text] [Related]
17. Induction of GRP78 by valproic acid is dependent upon histone deacetylase inhibition.
Shi Y; Gerritsma D; Bowes AJ; Capretta A; Werstuck GH
Bioorg Med Chem Lett; 2007 Aug; 17(16):4491-4. PubMed ID: 17566732
[TBL] [Abstract][Full Text] [Related]
18. Cytogenetic findings in untreated patients with essential thrombocythemia.
Panani AD
In Vivo; 2006; 20(3):381-4. PubMed ID: 16724675
[TBL] [Abstract][Full Text] [Related]
19. [Acute pancreatitis caused by valproic acid: apropos a case].
Bahamonde Carrasco A; Morán Blanco A; Olcoz Goñi JL
Gastroenterol Hepatol; 1996 May; 19(5):253-4. PubMed ID: 8752568
[TBL] [Abstract][Full Text] [Related]
20. Plasma vitamin values and antiepileptic therapy: case reports of pregnancy outcomes affected by a neural tube defect.
Candito M; Naimi M; Boisson C; Rudigoz JC; Gaucherand P; Guéant JL; Luton D; Van Obberghen E
Birth Defects Res A Clin Mol Teratol; 2007 Jan; 79(1):62-4. PubMed ID: 17120234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
